| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/06/2000 | WO1999000137A3 Induction of an activated myeloid dendritic cell phenotype |
| 01/06/2000 | WO1998001460A8 Brca1 compositions and methods for the diagnosis and treatment of breast cancer |
| 01/06/2000 | CA2337823A1 Mucosal targeting immunisation |
| 01/06/2000 | CA2336554A1 Marburg virus vaccines |
| 01/06/2000 | CA2336382A1 Methods and agents for the detection and modulation of cellular immunity to immune privileged antigens |
| 01/06/2000 | CA2335940A1 Particulate delivery systems and methods of use |
| 01/06/2000 | CA2335516A1 Methods of expanding and selecting disease associated t-cells |
| 01/06/2000 | CA2335508A1 Use of poxviruses as enhancer of specific immunity |
| 01/06/2000 | CA2335506A1 Mucosal targeting immunisation |
| 01/06/2000 | CA2334046A1 3'-exonuclease, its preparation and use |
| 01/06/2000 | CA2332494A1 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 01/06/2000 | CA2332181A1 Replication-defective recombinant adenovirus with mutated major late promoter |
| 01/06/2000 | CA2332175A1 Modularly constructed rna molecules having two sequence region types |
| 01/06/2000 | CA2331386A1 Human signal peptide-containing proteins |
| 01/06/2000 | CA2330546A1 Immune system molecules |
| 01/06/2000 | CA2330525A1 Human transferases |
| 01/06/2000 | CA2329264A1 Novel antigens of helicobacter pylori |
| 01/06/2000 | CA2301024A1 Monoclonal antibody 3-6-a specific to surface of dendritic cells among the peripheral blood leukocytes |
| 01/05/2000 | EP0969091A2 Leptin receptor gene-related protein |
| 01/05/2000 | EP0968723A1 Healing of wounds or fibrotic disorders using at least one agent against a growth factor |
| 01/05/2000 | EP0968722A1 Improved modified live BRSV vaccine |
| 01/05/2000 | EP0968721A2 Use of a composition comprising a peptide for the inhibition of HIV |
| 01/05/2000 | EP0968648A1 Mammalian nonhuman transgenic animal having a constitutive or inducible expression of the human endonexin II gene or its muteins or its fragments |
| 01/05/2000 | EP0968477A1 Coincidence detection method, products and apparatus |
| 01/05/2000 | EP0968299A1 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 01/05/2000 | EP0968297A1 Live recombinant avian vaccine using the avian infectious laryngotracheitis virus as vector |
| 01/05/2000 | EP0968293A1 Staphylococcus 3-dehydroquinate synthase |
| 01/05/2000 | EP0968290A1 Anti-alphavbeta3 humanized monoclonal antibodies |
| 01/05/2000 | EP0968285A1 Morphogenic proteins |
| 01/05/2000 | EP0968278A1 Attenuated polioviruses |
| 01/05/2000 | EP0968276A1 NOVEL clpL |
| 01/05/2000 | EP0968230A1 Oxidized fragments of apolipoprotein b and their use |
| 01/05/2000 | EP0968229A1 Antigenic peptides reacting with anti-ovary antibodies |
| 01/05/2000 | EP0968225A1 NOVEL spsB |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967996A2 Use of preparations containing anti-cd44 antibodies in the treatment of certain tumours and the suppression of immune reactions |
| 01/05/2000 | EP0967995A1 Composition comprising immunoglobulin |
| 01/05/2000 | EP0967994A1 Improved method for treatment and diagnosis of il-5 mediated disorders |
| 01/05/2000 | EP0967992A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 01/05/2000 | EP0967991A1 Infectious bursitis vaccine |
| 01/05/2000 | EP0967983A2 Methods for detection of kaposi's sarcoma-associated herpesvirus-like virus |
| 01/05/2000 | EP0721469B1 Anti-gp39 antibodies and uses therefor |
| 01/05/2000 | EP0652758B1 Diphtheria toxin vaccines |
| 01/05/2000 | EP0641357B1 Hiv protein epitopes immunologically homologous to hla |
| 01/05/2000 | EP0633894B1 Peptides of an antigen, capable of recognition by or induction of cytotoxic t lymphocytes, and method of their identification |
| 01/05/2000 | DE19819476C1 Polypeptid mit immunogenen Eigenschaften und veränderten biologischen Funktionen eines Proteins Polypeptide having immunogenic properties and altered biological function of a protein |
| 01/05/2000 | CN1240481A Infections clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 01/05/2000 | CN1240360A In oVO vaccination against newcastle disease |
| 01/05/2000 | CN1240349A Stable glassy state powder formulations |
| 01/04/2000 | US6011139 Polypeptides |
| 01/04/2000 | US6011138 Gamma-1 anti-human CD23 monoclonal antibodies |
| 01/04/2000 | US6011003 Vascular endothelial growth factor (vegf) inhibitors |
| 01/04/2000 | US6010905 Method for inducing monocytes to exhibit the phenotype of activated myeloid dendritic cells |
| 01/04/2000 | US6010901 Vectors |
| 01/04/2000 | US6010897 Expression of signal-peptide-free staphylokinases |
| 01/04/2000 | US6010895 Non-pathogenic strains of HIV-1 containing mutations in the NEF gene or the U3 region of the long terminal repeat |
| 01/04/2000 | US6010894 Using brain membrane receptor; forming vaccines |
| 01/04/2000 | US6010886 Receptor for oncostatin M |
| 01/04/2000 | US6010884 Recombinant binding proteins and peptides |
| 01/04/2000 | US6010881 Useful to screen compounds for antibiotic activity. polynucleotides that encode ribg polypeptides |
| 01/04/2000 | US6010878 Interleukin-1 β converting enzyme like apoptotic protease-6 |
| 01/04/2000 | US6010874 Early onset alzheimer's disease gene and gene products |
| 01/04/2000 | US6010872 Recombinant production of TGF-β type III receptor (betaglycan) polypeptides |
| 01/04/2000 | US6010855 Desaturase antigen of mycobacterium tuberculosis |
| 01/04/2000 | US6010845 Leukocyte adhesion assay |
| 01/04/2000 | US6010705 Attenuated, invasive vaccines against fish pathogens |
| 01/04/2000 | US6010704 Polypeptides and antibodies characteristic of papillomavirus, and diagnostic procedures and vaccines making use of them |
| 01/04/2000 | US6010703 Genetic engineering; inserting gene into gene encoding thymidine kinase |
| 01/04/2000 | US6010700 Polypeptides p57 or p9.5 of Borna disease virus and their use for diagnosis and immunization |
| 01/04/2000 | US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
| 01/04/2000 | CA2045658C Polypeptides having a .beta.-adremergic receptor activity in humans, involved_in the lipolytic response, nucleic acids coding for these polypeptides and use of these polypeptides for the screening of active substances on these polypeptides |
| 01/04/2000 | CA2026610C Chemically modified allergens and process for the preparation thereof |
| 12/30/1999 | DE19828322A1 New coccidiocide vaccine comprises inactivated, immunogenic sporocytes of pathogenic Eimeria species |
| 12/30/1999 | DE19827837A1 Preparation of conjugates for predictive testing, diagnosis, prophylaxis or therapy of immunological sensitization to chemicals |
| 12/30/1999 | CA2244211A1 Novel compounds |
| 12/29/1999 | WO1999067395A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses |
| 12/29/1999 | WO1999067393A2 Aav scleroprotein, production and use thereof |
| 12/29/1999 | WO1999067384A2 Prostate cancer-associated genes |
| 12/29/1999 | WO1999067366A1 Surface expression system of hepatitis b virus surface antigen and core antigen of hepatitis c virus by using ice-nucleation protein |
| 12/29/1999 | WO1999067362A1 Process for the in vitro replication of hcv |
| 12/29/1999 | WO1999067359A2 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes and hybriomas and monoclonal antibodies therefore |
| 12/29/1999 | WO1999067294A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 12/29/1999 | WO1999067293A1 Peptide composition as immunogen for the treatment of allergy |
| 12/29/1999 | WO1999067285A1 Particles of hcv envelope proteins: use for vaccination |
| 12/29/1999 | WO1999067283A2 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 12/29/1999 | WO1999066957A2 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 12/29/1999 | WO1999066955A1 The process of preparing immunoglobulin for intravenous injection by viruses double-sterilized without adding any protectant |
| 12/29/1999 | WO1999066954A1 Synthetic peptide vaccines for foot-and-mouth disease |
| 12/29/1999 | WO1999066953A2 Coccidiosis vaccine, method for the production thereof, and the use thereof |
| 12/29/1999 | WO1999066952A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides |
| 12/29/1999 | WO1999066951A2 Use of bi-specific antibodies for pre-targeting diagnosis and therapy |
| 12/29/1999 | WO1999066950A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 12/29/1999 | WO1999066947A1 Adjuvant therapy |
| 12/29/1999 | WO1999066941A1 Herbal extract composition and method with immune-boosting capability |
| 12/29/1999 | WO1999066923A1 Application for utility patent for improved enriched platelet wound healant |
| 12/29/1999 | WO1999066879A2 Systemic immune activation method using nucleic acid-lipid complexes |
| 12/29/1999 | WO1999058647A3 Human deadenylating nuclease, its production and its use |
| 12/29/1999 | WO1999058639A3 Structural proteins of fish pancreatic disease virus and uses thereof |
| 12/29/1999 | WO1999058563A3 Moraxella catharralis proteins |
| 12/29/1999 | WO1999057284A3 Attenuated influenza viruses |